EVOLVİNG PARADİGMS İN THE MANAGEMENT OF PRİMARY IMMUNE THROMBOCYTOPENİA İN ADULTS: FROM CORTİCOSTEROİDS TO TARGETED BİOLOGİC THERAPİES. Mediterr J Hematol Infect Dis 2026, 18 (1), e2026067. https://doi.org/10.4084/MJHID.2026.067.